Cargando…
CD24Fc: an emerging COVID-19 therapy
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916784/ https://www.ncbi.nlm.nih.gov/pubmed/35286842 http://dx.doi.org/10.1016/S1473-3099(22)00125-6 |
| _version_ | 1784668392454619136 |
|---|---|
| author | Eckhardt, Christina M O'Donnell, Max R |
| author_facet | Eckhardt, Christina M O'Donnell, Max R |
| author_sort | Eckhardt, Christina M |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8916784 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89167842022-03-14 CD24Fc: an emerging COVID-19 therapy Eckhardt, Christina M O'Donnell, Max R Lancet Infect Dis Comment Elsevier Ltd. 2022-05 2022-03-11 /pmc/articles/PMC8916784/ /pubmed/35286842 http://dx.doi.org/10.1016/S1473-3099(22)00125-6 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Eckhardt, Christina M O'Donnell, Max R CD24Fc: an emerging COVID-19 therapy |
| title | CD24Fc: an emerging COVID-19 therapy |
| title_full | CD24Fc: an emerging COVID-19 therapy |
| title_fullStr | CD24Fc: an emerging COVID-19 therapy |
| title_full_unstemmed | CD24Fc: an emerging COVID-19 therapy |
| title_short | CD24Fc: an emerging COVID-19 therapy |
| title_sort | cd24fc: an emerging covid-19 therapy |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916784/ https://www.ncbi.nlm.nih.gov/pubmed/35286842 http://dx.doi.org/10.1016/S1473-3099(22)00125-6 |
| work_keys_str_mv | AT eckhardtchristinam cd24fcanemergingcovid19therapy AT odonnellmaxr cd24fcanemergingcovid19therapy |